What Autolus Therapeutics PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 1 |
| Total trades | 2 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Piccina Cintia | U.S. CCO & Country Gen Manager | Sep 02 | Open-market sale · S | −6,713 | $2.34 | −$15.7K | 13,287 |
| Piccina Cintia | U.S. CCO & Country Gen Manager | Sep 01 | Exercise / conversion · M | +20,000 | $2.35 | +$47K | 20,000 |
Loading...
